Disease management
The latest approval marks DreaMed’s fourth clearance from the Food and Drug Administration.
The funding will help the company grow its team and go through clinical trials.
The company’s approach combines clinically-based treatment methods with a personalized digital platform so users can receive care in their own homes.
The program was tested in a 12-week pilot study that provided “promising evidence” that Type 2 diabetes can be reversed.
Eligible Onduo users can get a Fitbit Inspire 2, as well as access to Fitbit Premium.
Also, Medigo raises $1 million to expands its offerings to telemedicine.
The new clearance expands its insulin dosing support to bolus and premixed insulin titration for Type 2 diabetes.
Paige Prostate analyzes digitized biopsy slides and identifies areas that could be cancerous for the pathologist to review further.
Papa’s assistants, called Papa Pals, can help people set up the Milliman HealthIO app and any necessary devices.
It allows people to get medications and lab tests delivered to their homes, and to access personal care plans and specialists.